Earlier this month, Watson Pharmaceuticals and other business suffered more than the Federal Trade Commission (FTC) to postpone the competition for the allegations of illicit proceeds.

• 本月初，华生等多家制药商遭遇了联邦贸易委员会(FTC)推迟竞争换取非法收益的指控。